3 Things You Need to Know About Marijuana Stock Cara Therapeutics
Cara Therapeutics (NASDAQ: CARA) announced its second-quarter financial results after the market closed on Thursday. The next day, Cara stock soared. But it wasn't because of the financial numbers: Cara lost $9.3 million in the second quarter with no revenue whatsoever.
Instead, Cara Therapeutics' share price surged in large part because investors liked what they heard about the company's prospects in its conference call. Great expectations over those prospects have driven Cara stock up more than 60% so far this year.
In May, I wrote that investors were smart to buy Cara Therapeutics stock. Is that still true? Here are three things you need to know about Cara before jumping in.
Source: Fool.com
Cara Therapeutics Inc. Stock
€0.72
0.700%
With 8 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 4 € there is potential for a 454.02% increase which would mean more than doubling the current price of 0.72 € for Cara Therapeutics Inc..
